Skip to main content

Advertisement

Table 1 (abstract P108). See text for description

From: Proceedings of the 25th European Paediatric Rheumatology Congress (PReS 2018)

  Group 1 n=5 Normal MRI Group 2 n=16 Score >1 to 24 (median±SD 21±5.7) Group 3 n=9 Score >24 to 72 (median±SD 36±9.78) p
Age at study* 10(5-17) 12 (9-16) 14 (7-17) 0.001
Duration of disease* 2 (0-5) 4(1-8) 4(2-6) 0.02
AJ* 1 (0-5) 1(0-16) 2(0-8) ns
SIP ** 3 (60) 8 (50) 5(56) ns
LP** 1(20) 12(75) 4 (44) ns
LL ** 5 (4.5-5.5) 4.5 (3-7) 5 (3.5-6) ns
  1. *median (range) **Nº(%)